Five common cancers (lung, stomach, colorectal, liver, and breast) occur more often in communities with low employment rates or low incomes, per analysis of 16 years of data on Japanese adults
Peer-Reviewed Publication
This month, we're turning our attention to Breast Cancer Awareness Month, a time dedicated to increasing awareness, supporting early detection, and highlighting the ongoing research shaping the future of breast cancer treatment and prevention.
Updates every hour. Last Updated: 30-Oct-2025 00:11 ET (30-Oct-2025 04:11 GMT/UTC)
Breast cancer progression is driven by a complex ecosystem where cancer cells and their microenvironment communicate extensively. A recent Perspective article in Science Bulletin from a team led by Dr. Wenqian Wang (The Second Affiliated Hospital of Wenzhou Medical University), Professor Min Wu (University of Chinese Academy of Sciences, Wenzhou Institute), and Associate Professor Chunyan Hua (Wenzhou Medical University) reveals the crucial crosstalk between exosomes—small messengers released by cells—and metabolic reprogramming in breast cancer. This interaction influences tumor growth, resistance to therapy, and cancer stem cell survival. The study proposes innovative diagnostic and therapeutic strategies targeting this “exosome-metabolism axis”, offering new hope for more effective patient management.
Targeted cancer drugs known as CDK4/6 inhibitors have improved outcomes for patients with advanced or metastatic HR+/HER2- breast cancer, but many patients still eventually relapse and become resistant to therapy. New research co-headed by a Fox Chase Cancer Center scientist helps explain why — and offers three strategies for making treatment more effective.